Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 11   

Articles published

ENZN 1.04 +0.06 (5.65%)
price chart
Enzon Pharmaceuticals Surges Post-Klarman Sale
Today's midday gainers are Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Gilead Sciences, Inc. (NASDAQ:GILD) and Sirius XM Holdings Inc. (NASDAQ:SIRI).
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Stock Decreases
Dallas, Texas 03/25/2014 (FINANCIALSTRENDS) - Last week, a United States District Court denied Santaris Pharma's 2nd bid to have the patent- infringement lawsuit that was filed against it by the Isis Pharmaceuticals to be thrown out. The court ruled ...
Stocks in the Spotlight - Enzon Pharmaceuticals Inc(ENZN), MeetMe Inc (MEET ...  Techsonian (press release)
Related articles »  
Notable Movers - Discovery Laboratories, Inc. (NASDAQ:DSCO), Enzon ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) is engaged in licensing drug products. Its marketed drug products comprise PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for ...
Related articles »  
Klarman Closes Position On Enzon Ahead Of Likely Delisting
After shaving his position several times, Baupost Group LLC manager Seth Klarman has finally closed his position on Enzon Pharmaceuticals Inc (NASDAQ:ENZN) ahead of its likely de-listing from the NASDAQ. The company is pretty small compared to the ...
Worth Watching Stocks - Rio Alto Mining Ltd (RIOM), Chimera Investment ...
Enzon Pharmaceuticals Inc (ENZN) is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn's disease; ...
Related articles »  
Enzon Pharmaceuticals Inc Announces Auditor Change-Form 8-K
Enzon Pharmaceuticals Inc Announces $1.60 Special Dividend
Enzon Pharmaceuticals Inc Announces Special Dividend